19.06 USD
↘ 1.33 (6.52%)AT CLOSE (11:59 AM EDT)
Alumis Inc. Common Stock
ALMSNASDAQ • USD
19.06
↗ 0.00 (0.00%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
19.06
↗ 0.00 (0.00%)
Market: CLOSED
Open?$20.26
High?$21.00
Low?$19.04
Prev. Close?$20.39
Volume?1.4M
Avg. Volume?958.6K
VWAP?$19.82
Rel. Volume?1.50x
Bid / Ask
Bid?$15.96 × 100
Ask?$22.82 × 100
Spread?$6.86
Midpoint?$19.39
Valuation & Ratios
Market Cap?2.4B
Shares Out?123.4M
Float?71.1M
Float %?57.7%
P/E Ratio?N/A
P/B Ratio?4.29
EPS?-$1.86
Dividend?0.00%
Ex-Dividend?N/A
Shares of Alumis Inc. Common Stock (ALMS) are trading at $19.06. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Alumis Inc is a clinical-stage biopharmaceutical company with an initial focus on developing its two Tyrosine Kinase 2 ("TYK2") inhibitors: envudeucitinib ("envu"), an allosteric TYK2 inhibitor for the treatment of PsO and SLE; and A-005, a central nervous system ("CNS") penetrant allosteric TYK2 inhibitor, to offer the therapeutic benefit of TYK2 inhibition within the CNS for a broad range of neuroinflammatory and neurodegenerative diseases.
Themes
Address
280 EAST GRAND AVENUE
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-231-6625
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-231-6625
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?27
Short Sent.?19
Piotroski F-Score?0/9Weak
Altman Z-Score?10.49Safe
Confidence?49%Low
Short InterestVery High
Short % of Float?15.98%High
Short Interest?11.4M
Days to Cover?14.1
Free Float71.1M
Avg Daily Volume806.7K
Settlement Date2026-05-15
Financial Health
Current Ratio?7.51Strong
Quick Ratio?7.51Strong
Cash Ratio?0.90Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score58/100
P/E?N/A▾
P/B?4.29FAIR▾
Peers100
S&P42
P/S?289.22HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-5.3CHEAP▾
S&P97
EV/Sales?281.61HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-41.9%WEAK▾
S&P3
ROA?-35.4%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-377030000
Enterprise Value?$2.4B
Fundamentals ratios updated end of day